InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
57%
T+90 mean return
+10.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Desai Veeral, Directeur de la Stratégie et du Développement. Director active across 1 company, notably agilon health, inc.. In total, 17 filings have been published. Split: 1 buy · 0 sell. History available since 14 September 2021. The latest transaction was filed on 15 April 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations17 total
196,189 shares0Common StockSEC:0001628280-24-016653:0
11,956 sharesCommon StockSEC:0001628280-24-011773:0
Ideal exit: 9 Dec 2024 (T+270)
4,500 shares@ US$3.000.9% of flowCommon StockSEC:0001209191-23-028800:0
5,000 shares@ US$3.001.0% of flowCommon StockSEC:0001209191-23-025112:0
26,353 shares0Common StockSEC:0001209191-23-024666:0
22,710 shares@ US$3.004.7% of flowCommon StockSEC:0001209191-23-021209:0
60,000 shares@ US$3.0012.7% of flowCommon StockSEC:0001209191-23-019722:0
1,482 shares@ US$23.072.4% of flowCommon StockSEC:0001209191-22-051528:0
79,768 shares@ US$1.005.8% of flowCommon StockSEC:0001209191-22-043105:0
319,071 shares@ US$1.0023.4% of flowCommon StockSEC:0001209191-22-041801:0
106,357 shares@ US$1.000.035% mcap15.4% of flowCommon StockSEC:0001209191-22-039598:0
79,568 shares@ US$1.000.026% mcap11.2% of flowCommon StockSEC:0001209191-22-025550:0
106,357 shares@ US$1.000.035% mcap15.0% of flowCommon StockSEC:0001209191-22-025160:0
16,255 shares0Common StockSEC:0001209191-22-025009:0
197,291 shares@ US$1.000.063% mcap27.3% of flowCommon StockSEC:0001209191-22-020015:0
121,001 shares@ US$1.000.036% mcap15.6% of flowCommon StockSEC:0001209191-21-056200:0
121,001 shares@ US$1.007.6% of flowCommon StockSEC:0001209191-21-056200
17 of 17 declarations
About Desai Veeral
Veeral Desai is the Chief Strategy & Development Officer at agilon health, inc. He is responsible for developing and implementing the company's growth strategies. His role involves identifying new market opportunities and leading strategic development initiatives. Through his expertise, he contributes to the company's strategic direction and achieving its growth objectives.
